Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans
about
Bioinformatics Mining and Modeling Methods for the Identification of Disease Mechanisms in Neurodegenerative DisordersA Precision Medicine Initiative for Alzheimer's disease: the road ahead to biomarker-guided integrative disease modeling.Using Administrative Data to Examine Health Disparities and Outcomes in Neurological Diseases of the Elderly.ENIGMA and the individual: Predicting factors that affect the brain in 35 countries worldwide.Powerful and Adaptive Testing for Multi-trait and Multi-SNP Associations with GWAS and Sequencing Data.Human whole genome genotype and transcriptome data for Alzheimer's and other neurodegenerative diseasesThe Alzheimer's Disease Neuroimaging Initiative 3: Continued innovation for clinical trial improvement.Bayesian longitudinal low-rank regression models for imaging genetic data from longitudinal studiesAssociation analysis of rare variants near the APOE region with CSF and neuroimaging biomarkers of Alzheimer's disease.Quantitative multimodal multiparametric imaging in Alzheimer's disease.Association of EEG, MRI, and regional blood flow biomarkers is predictive of prodromal Alzheimer's disease.GWAS of longitudinal amyloid accumulation on 18F-florbetapir PET in Alzheimer's disease implicates microglial activation gene IL1RAP.Genetic Influences on Plasma Homocysteine Levels in African Americans and Yoruba NigeriansAn Alzheimer's Disease Genetic Risk Score Predicts Longitudinal Thinning of Hippocampal Complex Subregions in Healthy Older Adults.Hippocampal Sclerosis of Aging, a Common Alzheimer's Disease 'Mimic': Risk Genotypes are Associated with Brain Atrophy Outside the Temporal Lobe.Genome-wide association study of language performance in Alzheimer's disease.Promising Targets for the Treatment of Neurodegenerative Diseases.Near-infrared spectroscopy (NIRS) and vagus somatosensory evoked potentials (VSEP) in the early diagnosis of Alzheimer's disease: rationale, design, methods, and first baseline data of the Vogel study.The Relationship Between Apolipoprotein ε4 Carrier Status and Sleep Characteristics in Cognitively Normal Older Adults.Imaging-wide association study: Integrating imaging endophenotypes in GWAS.Network approaches to systems biology analysis of complex disease: integrative methods for multi-omics data.Retention of normal glia function by an isoform-selective protein kinase inhibitor drug candidate that modulates cytokine production and cognitive outcomes.Polygenic risk of Alzheimer disease is associated with early- and late-life processes.State of Play in Alzheimer's Disease Genetics.Association of cancer and Alzheimer's disease risk in a national cohort of veterans.Pro198Leu polymorphism affects the selenium status and GPx activity in response to Brazil nut intake.Age-related neurodegenerative disease associated pathways identified in retinal and vitreous proteome from human glaucoma eyes.Pattern Discovery in Brain Imaging Genetics via SCCA Modeling with a Generic Non-convex PenaltyMapping longitudinal scientific progress, collaboration and impact of the Alzheimer's disease neuroimaging initiative.NETWORK-BASED GENOME WIDE STUDY OF HIPPOCAMPAL IMAGING PHENOTYPE IN ALZHEIMER'S DISEASE TO IDENTIFY FUNCTIONAL INTERACTION MODULES.Codon bias among synonymous rare variants is associated with Alzheimer's disease imaging biomarker.A Novel SCCA Approach via Truncated ℓ1-norm and Truncated Group Lasso for Brain Imaging Genetics.DNA damage and neurodegenerative phenotypes in aged Ciz1 null mice.Alzheimer disease brain atrophy subtypes are associated with cognition and rate of decline.Identifying Associations Between Brain Imaging Phenotypes and Genetic Factors via A Novel Structured SCCA Approach.Sparse Canonical Correlation Analysis via Truncated ℓ1-norm with Application to Brain Imaging Genetics.CYP2C19 variant mitigates Alzheimer disease pathophysiology in vivo and postmortem.GPU Accelerated Browser for Neuroimaging Genomics.Sex Differences in Cognitive Decline in Subjects with High Likelihood of Mild Cognitive Impairment due to Alzheimer's disease.Genetic variation affecting exon skipping contributes to brain structural atrophy in Alzheimer's disease.
P2860
Q26774418-1DF97399-6475-458C-8CB3-EFA0C8A0E426Q30235315-099C8086-533B-42A2-B05F-84EC50B98391Q30999714-BDB01072-1E6F-415F-B0E1-3F7F2ACAF5B9Q31031716-F2EC4C20-F479-4D16-8029-BA59A604873FQ31076621-FC264E64-B19F-45C0-832A-AB5577BDFD6FQ31136073-868BCBC2-F69B-487F-95E8-2C88A436EAB8Q31147579-69C85EFC-9041-456F-B3B3-29B06E813A6EQ31158488-697305DD-F6DF-4710-8287-AEA340BB034DQ33770976-D96A1B01-0709-44BB-B1E6-376542065C19Q36164757-BCD5E265-F255-4E09-B955-F0A918CBF250Q36239946-337BD5F6-DF4D-401D-A8DA-5B45BEB56FB3Q36351585-7E2532F4-0598-45C3-BD76-C84EE5EBB772Q36770198-A4EFB651-6631-49AB-9361-60B0C6D20DDFQ37096748-86C4486F-CD47-4A07-8500-F0D2E33EB9A2Q37161390-71CEE9DA-80B7-4C66-84FB-32BF93949E27Q38376090-6139331F-5F8C-4C71-B3C5-89F8C6AAF1EEQ38562084-C2DC9565-C018-42D9-A488-6A679227DE14Q38597149-E3AC7078-CC25-4F4C-AF70-8C687B18B9CBQ38659728-D9C3455E-E9E4-4E3B-AB33-3CDA940D19CCQ38665727-3D5F1134-8B6F-47DF-B3D0-8F86B9D6E534Q38692645-722BCFF5-67F3-4E11-89EF-CA53ACB5179CQ38708742-4A75F49E-9A5E-40C2-9BFE-F48139716EC0Q38844567-4EB3F8BF-7CC3-4BB0-93D1-A44D27568F82Q39307376-CEE2B370-B05B-43EA-827F-DB83923CD4C1Q40121614-22DFB70F-A2E1-4F78-A927-FFB22D3F0D23Q40217452-EFFD1F7F-43A2-46A9-9C1D-A4088D0EA54AQ42281478-491CF696-7F88-4A8E-AB9C-ED8DB86E26C5Q42629928-51B43771-4004-44F1-A227-65FFF996E19FQ45077670-B1905DA5-2168-46D4-AD66-882EDD39F965Q45945134-67421F26-9544-4A5B-8CB6-A1AB4FA0F659Q47169481-38958F21-6C2B-4578-96A3-E7C88AB11C5CQ47316860-A423A161-FAD8-4F49-83BF-CD3B954812D2Q47386934-DA0CDFF2-D402-4938-BE42-100593CA8E5EQ47588927-AF7DD45C-D633-412F-A8AA-074B4D105465Q47702005-2A8F509E-E67C-4637-8C6A-74408E3F6BA4Q49073207-652D7049-D621-442F-AB80-61001403B27DQ50281847-1AEC1CE0-5FF0-4DDC-A875-3DD5231276CDQ52310540-D4FE1F2E-D979-4B41-B16A-4062FD84225EQ55010546-95CC875C-5DD0-4CA3-B017-CA6804919F65Q55360400-AA787A37-53EF-4607-A766-6557AF54E607
P2860
Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans
description
2015 nî lūn-bûn
@nan
2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Genetic studies of quantitativ ...... ress, opportunities, and plans
@ast
Genetic studies of quantitativ ...... ress, opportunities, and plans
@en
Genetic studies of quantitativ ...... ress, opportunities, and plans
@nl
type
label
Genetic studies of quantitativ ...... ress, opportunities, and plans
@ast
Genetic studies of quantitativ ...... ress, opportunities, and plans
@en
Genetic studies of quantitativ ...... ress, opportunities, and plans
@nl
prefLabel
Genetic studies of quantitativ ...... ress, opportunities, and plans
@ast
Genetic studies of quantitativ ...... ress, opportunities, and plans
@en
Genetic studies of quantitativ ...... ress, opportunities, and plans
@nl
P2093
P2860
P50
P3181
P1476
Genetic studies of quantitativ ...... ress, opportunities, and plans
@en
P2093
Holly D Soares
John S K Kauwe
Kwangsik Nho
Leanne M Munsie
Nadeem Sarwar
Steven G Potkin
Vijay K Ramanan
Xiaohui Yao
Xiaolan Hu
P2860
P304
P3181
P356
10.1016/J.JALZ.2015.05.009
P407
P50
P577
2015-07-01T00:00:00Z